Newmont MD Rodgers sells 4,443 NEM shares

Newmont Corp executive Mark C. Rodgers, MD Africa-Asia Pacific, reported an open-market sale of 4,443 shares of Newmont common stock on February 27, 2026 at $130.00 per share.

Filing Impact

(Very High)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Newmont Corp executive Mark C. Rodgers, MD Africa-Asia Pacific, reported an open-market sale of 4,443 shares of Newmont common stock on February 27, 2026 at $130.00 per share. After this transaction, he directly holds 27,807 shares. The sale was executed under a pre-established Rule 10b5-1 trading plan dated November 24, 2025.

Insider Trade Summary

Net Seller: 4,443 shares

Net Sell 1 txn

Insider Rodgers Mark C

Role MD, Africa-Asia Pacific

Sold 4,443 shs ($578K)

Type	Security	Shares	Price	Value
Sale	Common Stock, $1.60 par value	4,443	$130.00	$578K

Holdings After Transaction: Common Stock, $1.60 par value — 27,807 shares (Direct)

Footnotes (1)

F1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan dated November 24, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Newmont (NEM) report for Mark C. Rodgers?

Newmont (NEM) reported that executive Mark C. Rodgers sold 4,443 shares of common stock. The open-market sale occurred on February 27, 2026 at $130.00 per share under a Rule 10b5-1 trading plan.

At what price did Mark C. Rodgers sell Newmont (NEM) shares?

Mark C. Rodgers sold Newmont (NEM) common shares at $130.00 per share. The Form 4 shows a single open-market transaction for 4,443 shares executed on February 27, 2026 pursuant to a Rule 10b5-1 trading plan.

How many Newmont (NEM) shares does Mark C. Rodgers own after this sale?

After the reported transaction, Mark C. Rodgers directly owns 27,807 Newmont (NEM) common shares. This post-transaction balance is disclosed in the Form 4 as the total number of shares beneficially owned following the sale.

Was the Newmont (NEM) insider sale by Mark C. Rodgers under a 10b5-1 plan?

Yes. The Form 4 states the sale was effected under a Rule 10b5-1 trading plan dated November 24, 2025. Such plans prearrange trades, allowing insiders to sell shares according to predetermined instructions.

What role does Mark C. Rodgers hold at Newmont (NEM)?

Mark C. Rodgers serves as an officer of Newmont (NEM) with the title MD, Africa-Asia Pacific. His position and this insider sale are both disclosed in the Form 4 reporting the February 27, 2026 transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/02/2026 - 04:39 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rodgers Mark C

(Last)

(First)

(Middle)

6900 E. LAYTON AVE.

SUITE 700

(Street)

DENVER

80237

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
NEWMONT Corp /DE/ [ NEM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	MD, Africa-Asia Pacific

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $1.60 par value	02/27/2026		S		4,443⁽¹⁾	D	$130	27,807	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan dated November 24, 2025.

	/s/ Logan H. Hennessey, Attorney-in-fact for Mark C. Rodgers	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR